Stryker Corporation · NYSE:SYK

Stryker — Morgan Stanley 18th Annual Virtual Global Healthcare Conference (September 2020)

10 slides from Stryker's conference presentation, Sep 15, 2020

  1. Slide 1: Stryker

    Stryker Kevin A. Lobo Chairman and Chief Executive Officer 1

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains information that includes or is based on forward-looking statements within the meaning of the federal securities laws that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in

  3. Slide 3: Mission and Values

    Mission Together with our customers, we are driven to make healthcare better. Values Integrity Accountability People Performance We do what’s right We do what we say We grow talent We deliver 3

  4. Slide 4: Our recovery curve

    Our recovery curve… Q2 Sales $2.8B –24.3% vs 2019 Q2 Adjusted EPS $0.64 -67.7% vs 2019 4

  5. Slide 5: Product/business innovation continues

    Product/business innovation continues Surpass Evolve ProCuity Ambulatory Surgery Flow Diverter MedSurg Bed Center Business • First 64 wire FDS in the US • Versatility • Product breadth • Optimized delivery/flow diversion • Wireless connectivity • Sales solutions • Advanced fall prevention • Financin

  6. Slide 6: Mako 1,000th install

    Mako 1,000th install Demand remains strong for our Mako robotic technology Success in Stryker and competitive accounts Accelerating sales into ASCs Utilization increasing across both hips and knees Driving shift towards cementless knees Solid innovation pipeline 6

  7. Slide 7: Long-term sustainable financial growth

    Long-term sustainable financial growth Sales growth at the high end of med tech, which allows us to drive… Sales growth 30 to 50 basis points of annual EPS operating income improvement growth over the next 5 years Operating leverage EPS growth of at least 9% annually Financial efficiency 7

  8. Slide 8: 8

    8

  9. Slide 9: Appendix A

    Appendix A RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non- GAAP financial measures, including: percentage sales growth; percentage sa

  10. Slide 10: Reconciliation of reported net sales growth to organic net sales growth

    Reconciliation of reported net sales Reconciliation of net earnings per diluted share to adjusted growth to organic net sales growth net earnings per diluted share Three Months Three Months June 30 June 30, 2020 2019 2020 Diluted Diluted Reported Net Sales Growth (24.3) % EPS EPS Less: Foreign Curre

Stryker — Morgan Stanley 18th Annual Virtual Global Healthcare Conference (September 2020) on 6ix